BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.

BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.

Item
http://www.wikidata.org/entity/Q40421282
Therapeutic use of Aldara in chronic myeloid leukemia.Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines.Predictive approaches for drug combination discovery in cancer.Contributions of MET activation to BCR-ABL1 tyrosine kinase inhibitor resistance in chronic myeloid leukemia cells.STAT5 signaling is required for the efficient induction and maintenance of CML in mice.Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia (CML).Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib.
P2860

BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib.

Item
http://www.wikidata.org/entity/Q40421282
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
BCR-ABL gene amplification and ...... eukemia treated with imatinib.
@en
type
label
BCR-ABL gene amplification and ...... eukemia treated with imatinib.
@en
prefLabel
BCR-ABL gene amplification and ...... eukemia treated with imatinib.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
BCR-ABL gene amplification and ...... eukemia treated with imatinib.
@en
P2093
P304
P31
P356
10.1016/J.CANCERGENCYTO.2004.09.021
P433
P478
P50
P577
P698
P921